EUVIMEDEUVIMED entdecken
Systematische Übersicht

Selective Cyclooxygenase-2 Inhibitors in Preclinical Rodent Models of Depression and Post-traumatic Stress Disorder: A Systematic Review of Behavioral, Neuroinflammatory, and Molecular Mechanisms

Alexey Sarapultsev iD, Maria Komelkova, Irina Utepova iD, Evgenii Gusev, Desheng Hu, Alexander Trofimov iD, Tursonjan Tokay, Elena Kondaurova, Vladimir Naumenko

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00568 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Alexey Sarapultsev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Russian-Chinese Education and Research Center of System Pathology, South Ural State University, 76 Lenin Prospekt, Chelyabinsk 454080, Russia. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Cyclooxygenase 2 Inhibitors, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression and post-traumatic stress disorder (PTSD) are treatment-resistant neuropsychiatric conditions closely linked to chronic neuroinflammation. Given the limitations of current pharmacotherapies, selective cyclooxygenase-2 (COX-2) inhibitors have emerged as promising candidates for modulating neuroimmune and oxidative pathways. This systematic review evaluated the efficacy of selective COX-2 inhibitors in improving behavioral and neuroinflammatory outcomes in rodent models of chronic stress or systemic inflammation relevant to depression and PTSD. A comprehensive search was conducted across PubMed, Scopus, Web of Science, and other databases for in vivo rodent studies published between 2010 and 2025. Inclusion criteria required validated chronic stress or inflammation paradigms (≥7 days), selective COX-2 inhibitors, and reporting of quantitative behavioral and neuroinflammatory end points. Thirty-four studies met eligibility criteria and were synthesized both qualitatively and via targeted random-effects meta-analysis for depression-like behaviors. COX-2 inhibitors such as celecoxib, meloxicam, and etoricoxib reduced forced swim test immobility by approximately 40% and increased sucrose preference by 25-30%, effects comparable to or exceeding SSRIs. Reductions in IL-6, TNF-α, and COX-2 expression ranged from 30% to 60%, along with suppression of the NF-κB pathway and markers of glial activation (Iba-1, GFAP). Concurrent activation of antioxidant pathways via Nrf2/HO-1 led to elevated levels of SOD, GSH, and BDNF, which correlated with behavioral improvements. A pooled meta-analysis (n = 15 comparisons) revealed a large standardized effect size (Hedges' g = 3.19; 95% CI: 2.14-4.25; I2 = 92.2%) in favor of COX-2 inhibition. While findings consistently support these agents' antidepressant- and anxiolytic-like efficacy in chronic stress models, their translational potential is limited by male-restricted samples (91% of studies), underreporting of effect sizes, and a scarcity of long-term durability assessments. These results support continued investigation of COX-2 inhibitors as adjunctive treatments in stress-related psychiatric disorders, with an emphasis on sex-stratified analyses and standardized behavioral and molecular reporting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticCyclooxygenase 2 InhibitorsDepressionAnimalsDisease Models, AnimalNeuroinflammatory DiseasesRodentiaInflammationAntidepressive Agents

Stichwörter der Autor:innen

NF-κB signalingNrf2 pathwaycyclooxygenase 2 inhibitorsdepressionneuroinflammationoxidative stresspost-traumatic stress disorderpreclinical neurosciencerodent modelssynaptic plasticity

Substanzen

Cyclooxygenase 2 InhibitorsAntidepressive Agents

Autor:innen und Institutionen

  • Russian-Chinese Education and Research Center of System Pathology, South Ural State University, 76 Lenin Prospekt, Chelyabinsk 454080, Russia.
  • Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Science, 106 Pervomaiskaya street, Ekaterinburg 620049, Russia.
  • Department of Organic and Biomolecular Chemistry, Ural Federal University, 19 Mira street, Ekaterinburg 620002, Russian Federation.
  • Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.
  • Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.
  • China-Russia Medical Research Center for Stress Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.

ORCID-Profile: Alexey Sarapultsev, Irina Utepova, Alexander Trofimov

Förderung

  • Russian Science Foundation

Zitieren

APA

Sarapultsev, A., Komelkova, M., Utepova, I., Gusev, E., Hu, D., Trofimov, A., Tokay, T., Kondaurova, E., & Naumenko, V. (2025). Selective Cyclooxygenase-2 Inhibitors in Preclinical Rodent Models of Depression and Post-traumatic Stress Disorder: A Systematic Review of Behavioral, Neuroinflammatory, and Molecular Mechanisms. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00568

Vancouver

Sarapultsev A, Komelkova M, Utepova I, Gusev E, Hu D, Trofimov A, et al. Selective Cyclooxygenase-2 Inhibitors in Preclinical Rodent Models of Depression and Post-traumatic Stress Disorder: A Systematic Review of Behavioral, Neuroinflammatory, and Molecular Mechanisms. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00568

BibTeX
@article{Sarapultsev2025,
  author = {Sarapultsev, Alexey and Komelkova, Maria and Utepova, Irina and Gusev, Evgenii and Hu, Desheng and Trofimov, Alexander and Tokay, Tursonjan and Kondaurova, Elena and Naumenko, Vladimir},
  title = {Selective Cyclooxygenase-2 Inhibitors in Preclinical Rodent Models of Depression and Post-traumatic Stress Disorder: A Systematic Review of Behavioral, Neuroinflammatory, and Molecular Mechanisms},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00568}
}
Kostenlos starten →